Was a video tape shown, and what was on it? Was there any scientific talk about the FDA's objections re: natural history and Dystrophin measurements, or at least an explanation as to why the FDA was relying on bad data (ie. studies that included Beckers). I know Wilton and Mendell spoke, but what other scientists were there and what did they add? Thanks.
Christine hasn't tweeted today. I think you are referring to Jenn, and she doesn't mention a video tape or really describe exactly what happened in detail.
I am not suggesting that he was short the stock. All I am saying is that he got replaced by a coworker who could have been appointed director in the first place. It seems like an insult, so I am suggesting that Woodcock was not happy with his job performance or he really screwed something up.
Billy Dunn was not some outside guy. He was also a deputy director at the Division of Neurology if I read his bio correctly. They could have picked him on day one. It would be one thing if some prominent outside guy or girl was brought in to be the new Director, but this seems like an insult to replace him with a colleague. Am I reading this right that they are basically telling Bastings that they are unhappy with the job he is doing?
I believe the people pitching the case JW is referring to are the parent/advocates, if she is talking about etep. I still like another 30 boys to erase any questions about dystrophin measurements that were put in the FDA's heads by competitors or Hoffman, which is what I think happened.
Sorry, if this is an ignorant question grey, but why will the FDA have to explain their exact position in writing? Why can't they just ask for another study? As to jrrt1, I am suggesting they will go this route strictly for #$%$ covering. I agree they made a mistake in November, and that clinical benefit has been shown, but if they insist on another trial of any kind, I would think AA on positive dystrophin in the new kids would be a better #$%$ cover than clinical benefit on the ten boys even after another year of stability, and that #$%$umes no more mishaps like the broken leg. In any event, my basic point was that I read the interview as good news, not bad, and was wondering whether others agreed?
I read the same article you guys did, and I was struck by her statement that that if you came to them with great p2 data, just go ahead and repeat it with an open label study of another 30 patients. If, and i acknowledge its a big if, she is thinking about Etep, and if this is in fact what they are converging on at the FDA regarding Etep, I would take it as a victory. I don't think they would make them wait two years for clinical results. I think some stabilization with (and this is key) 100% dystrophin production along with continued stability in the P2 kids would be sufficient for some sort of approval while the P3 was on going. I read it as a positive (except for the petulant characterization), and if JW is really talking AA after another study, she is not talking about a full P3.
If the stock doesn't get crushed tomorrow, is it too late to short? Will there be more shoes to drop, or have they gotten everything out of the way, at least when it comes to this quarter and any forward guidance? I know all you can do is give an opinion, but what's your read?
Ralph, is this the first quarter where you have are aware of major insurance company push back on pricing? I have heard rumors about this for a while, but the company keeps denying any push back on rates. Has something changed recently? Also, any reason to suspect that they use their shelf, other than teh stock price (ie. any cash problems or expenses coming up)?
For all you people who are so excited about the upcoming short squeeze, this is it. The only buyers are people who shorted without a borrow on the 31st and the 2nd who are now being bought yesterday and today. This, is all you are going to get, and as soon as it is done, there will be no buyers and no liquidity for anyone who wants to get out. In other words, today is as good as it gets, imo.
As long as you are making up lies, why don't you claim they will have to pay out a $100 a share dividend? It sounds even scarier.
The past week was an anomaly. It used to only trade a few thousand shares a day. The stock is worth around $5.70. The only people who are buying are day traders trading on god knows what theory, and people who are short who are covering. There is not even hope that a few people will try to corner the market (at least not for very long because in a few months the merger will be complete and all of the nontransferable dividends will turn into freely tradable shares). As more and more people speak to the company and Nasdaq and realize there are no dividends coming and that the stock has around $5.70 in cash and that is all its worth, and whoever is short finishes covering, this stock will drift lower, and since you are not going to get your cash until they liquidate, which will take a long time, and since the new shares will hit the market in a few months, this could easily overshoot to the downside as the remaining people with higher (some much higher) cost bases realize they are never getting their money back and through in the towel. What is $5.70 worth to you if you are not going to get it in a year or two and it is tying up your capital? And what are you going to do with your position if it is large and the volume continues to dry up?
The economic interests in the real estate holdings of GYRO were distributed to shareholders as a nontransferable security as part of the special dividend on the 30th. The company estimated the value of the real estate at $20.70. If you are buying gyro now, all you are getting is some cash and cash equivalents which the company estimates are worth $5.70.
Or you could do what I did and actually call the CEO and have him walk through everything and confirm you are not getting any dividend if you bought after Monday. Then you could do what I did and call Nasdaq and have them confirm the same thing. Both confirmed the last day to buy the stock and be entitled to the $10.89 dividend was Dec 26th. The record date was Dec 31 and stock takes three business days to settle and it is not trading with due bills or any special exception to the ex dividend date. Everyone I talked to confirmed this. The company's press release could have been written better, but it was legally sufficient, and you should call them to verify what I am telling you.
You had to be an owner on the 31st. Stocks take 3 days to settle, so you had to buy on the 26th. This is what the shareholder presentation exhibit 99.1 to 8-k file on dec27th says. This is what Bloomberg says, what te company says, what Nasdaq says if you call either of them. The dividend is in the form of a nontransferable security so it is not trading with due bills. Call Nasdaq and ask them if you don't believe me.
From marketwatch: Note the words "payable to shareholders as of Decmber 31st" meaning you must have been a shareholder as of December 31st, ie that is the record date. No arguments that this entire release could have been more clear, but you have no had several days to call the Nasdaq and the company if you don't understand.
The transfer of the properties by Gyrodyne to GSD will result in the recognition of approximately $28.4 million of capital gain income by Gyrodyne. Giving effect to offsetting deductions, Gyrodyne expects to have approximately $17 million in REIT income for 2013. In order to satisfy applicable REIT distribution requirements, Gyrodyne has declared an additional dividend, payable to Gyrodyne shareholders as of December 31, 2013. Such dividend, which will be payable on January 31, 2014, will be in the form of notes ("Dividend Notes") aggregating $16,150,000 ($10.89 per share) in principal amount unless the board otherwise determines to pay all or part of such dividend in cash and subject to any applicable law, rule or regulation. The principal terms of such Dividend Notes are attached as Annex A to this press release.
Would you please link to what you are looking at? Thanks.
payable to shareholders of record December 31. Not be shareholder of record December 31, given that settlement takes 3 trading days , you had to buy on the December 26th. It often take a moth for the dividend to get paid. that is to the crucial date. call the damn nasdaq if you don't believe me. Ask what the last day you could buy Gyro and get the dividend was. Ask if you bought gyro today do you get the dividend. Call the company and repeat the same question. At this point it is obvious you are just lying.